Well the guidance if you include Jac for FY (and add back the $1m est costs) gets you to $90m U EBITDA. Jac f/c FY17 was 32m, Cont EBITDA was 51m, and there is $7m of growth on a base of 83, which is 8.4% growth on that base. Also Jac earned 9m ebitda - that is 28% of the FY for last year, in two months, rather than 3.5 months. Guidance may also be conservative.
All sounds good to me on that basis - keen to know if I am missing something - so please let me know.
Well the guidance if you include Jac for FY (and add back the...
-
- There are more pages in this discussion • 269 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add WEB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.32 |
Change
-0.030(0.69%) |
Mkt cap ! $1.709B | |||
| Open | High | Low | Value | Volume |
| $4.33 | $4.41 | $4.28 | $8.016M | 1.837M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 410057 | $4.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.33 | 59065 | 55 |
View Market Depth
| Last trade - 14.36pm 13/11/2024 (20 minute delay) ? |
| WEB (ASX) Chart |